Home > Balance Sheet > CIPLA

CIPLA
Total Non-Current Liabilities

    Back to Balance Sheet
CIPLA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for CIPLA
Please provide your vote to see the results

CIPLA Last 5 Year Total Non-Current Liabilities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Total Non-Current Liabilities ₹82 Cr₹184 Cr₹622 Cr₹1,660 Cr₹2,972 Cr

What is the latest Total Non-Current Liabilities ratio of CIPLA ?

The latest Total Non-Current Liabilities ratio of CIPLA is ₹82 Cr based on Mar2024 Consolidated results.
Year Total Non-Current Liabilities
Mar2024₹82 Cr
Mar2023₹184 Cr
Mar2022₹622 Cr
Mar2021₹1,660 Cr
Mar2020₹2,972 Cr

How is Total Non-Current Liabilities of CIPLA Trending?

Years Total Non-Current Liabilities % Change
Mar2024 ₹82 Cr
-55.36
Mar2023 ₹184 Cr
-70.48
Mar2022 ₹622 Cr
-62.55
Mar2021 ₹1,660 Cr
-44.15
Mar2020 ₹2,972 Cr -

Compare Total Non-Current Liabilities of peers of CIPLA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CIPLA ₹118,164.0 Cr 3.4% 0.1% -3.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹404,900.0 Cr -1.3% 4.7% 3.3% Stock Analytics
DIVIS LABORATORIES ₹148,474.0 Cr 1.9% 1.5% 41.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹105,849.0 Cr -4.8% 1.9% 20.3% Stock Analytics
MANKIND PHARMA ₹97,009.6 Cr -4% 4% -1.9% Stock Analytics
DR REDDYS LABORATORIES ₹92,553.6 Cr -0.1% -1% -11.3% Stock Analytics


CIPLA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
CIPLA

3.4%

0.1%

-3.1%

SENSEX

-1.5%

1.1%

1.2%


You may also like the below Video Courses